title: Hypertension as a determinant of survival for patients treated with home dialysis.
abstract: BACKGROUND
  Previous studies of the risks of hypertension for dialysis patients have yielded conflicting results. The aim of this study was to investigate, in a home dialysis population with low rates of diabetes and antihypertensive drug use, whether blood pressure (BP) was an independent risk factor for survival.
  
  
  METHODS
  The outcome of 168 consecutive patients (94 male, 88% Caucasian), aged 48 years (SD 16), who began home hemodialysis (HD; N = 124) or home continuous ambulatory peritoneal dialysis (CAPD; N = 44) between January 1, 1985 and December 31, 1994 were analyzed retrospectively. Only 4.7% of patients took antihypertensive drugs while on dialysis. The patients were followed to December 31, 1998 with the primary outcome being all-cause mortality. Censoring events were transplantation, transfer to another center and treatment modality change. The Cox proportional hazard model was used with baseline predictors.
  
  
  RESULTS
  Seventy-one patients died and the median overall survival was 4.2 years (5.6 on HD, 2.2 on CAPD, P < 0.0001). Mean BP at start of dialysis predicted survival on its own (P = 0.0009) and in the joint Cox model (P = 0.047). Other significant predictors in the joint model were age [10 year increase, relative hazard (RH) = 1.55, P = 0.0008], albumin (10 g/L decrease, RH = 2.05, P = 0.007), diabetes (RH = 3.42, P = 0.015) and peripheral vascular disease (RH = 2.19, P = 0.02) but not dialysis modality (RH = 1.63, P = 0.13). High and low mean blood pressure (BP) values at the start of dialysis were associated with the highest mortality.
  
  
  CONCLUSIONS
  Among the home dialysis patients, most of whom did not require antihypertensive drugs, hypertension was a risk factor for survival and patients with mid-range BP values survived the longest.
authors.affiliation: Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand. kevin.lynn@cdhb.govt.nz
authors.forename: Kelvin L
authors.initials: KL
authors.lastname: Lynn
authors.forename: David O
authors.initials: DO
authors.lastname: McGregor
authors.forename: Todd
authors.initials: T
authors.lastname: Moesbergen
authors.forename: Adrian L
authors.initials: AL
authors.lastname: Buttimore
authors.forename: Judith A
authors.initials: JA
authors.lastname: Inkster
authors.forename: J Elisabeth
authors.initials: JE
authors.lastname: Wells
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002648:Child; D002675:Child, Preschool; D005260:Female; D006437:Hemodialysis, Home / Q000401:mortality*; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000401:mortality*; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D016019:Survival Analysis
chemical_list: D000959:Antihypertensive Agents